Facebook Pixel 13th Bengaluru INDIA NANO 2024 brings together 1018 delegates, 3,000+ visitors | Bio Spectrum – business – Lesen Sie diese Geschichte auf Magzter.com
Mit Magzter GOLD unbegrenztes Potenzial nutzen

Mit Magzter GOLD unbegrenztes Potenzial nutzen

Erhalten Sie unbegrenzten Zugriff auf über 9.000 Zeitschriften, Zeitungen und Premium-Artikel für nur

$149.99
 
$74.99/Jahr

Versuchen GOLD - Frei

13th Bengaluru INDIA NANO 2024 brings together 1018 delegates, 3,000+ visitors

Bio Spectrum

|

September 2024

The 13th edition of Bengaluru INDIA NANO 2024, organised by the Department of Science & Technology, Government of Karnataka, Karnataka Science & Technology Promotion Society (KSTePS), and Jawaharlal Nehru Centre for Advanced Scientific Research (JNCASR) concluded on August 3 with participation of 1018 delegates, 11 countries including Korea, Morocco, USA, UK, France, Canada, Germany, Netherlands, Russia, Japan, and Poland, 49 exhibitors comprising 21 startups and 28 industry and institutes, and 200 posters. The exhibition had a footfall of 3,000+ visitors.

13th Bengaluru INDIA NANO 2024 brings together 1018 delegates, 3,000+ visitors

The conference featured 81 distinguished speakers across 41 sessions, exploring a broad range of topics from cutting-edge research to practical industry applications in nanotechnology. Over 200 young attendees participated in the pre-conference tutorials.

During the two days sessions on "Nano in Healthcare", Prof. Dhirendra Katti, Director, IIT Goa spoke on 'Development of a Vaccines/Nano vaccines for Multi-drug Resistant Diarrhoea'; Dr Jiban Jyoti Panda, Associate Professor, Institute of Nano Science and Technology, Mohali spoke on 'Brain targeting Small Molecular Nanomedicines', Prof. Biman B. Mandal, Professor, IIT Guwahati shared his views on 'Nano-Composite Silk Hydrogel for Spatiotemporal, Targeted and On-Demand Controlled Release of Chemotherapeutics: An In Vivo Approach toward Suppressing Solid Tumour Growth', This session was chaired by Prof. Swaminathan, Professor & Director, SASTRA University.

Dr Praveen Kumar Vemula, Faculty, DBT INSTEM chaired a second session on Nano in Healthcare in which Prof. Neetu Singh, Professor & Head, Center for Biomedical Engineering, Indian Institute of Technology Delhi shared her views on the topic '3D Liver Platforms For In-Situ Disease Staging' and in his presentation Prof. Bikramjit Basu, Professor, IISc Bangalore touched upon 'Size-tailored Gold Nanoparticles: Novel electroactuators to guide stem cell differentiation and as bacteriotoxic agents' and Prof. K. Uma Maheswari, Professor, Sastra University spoke on Smart Non-intervention for Therapy.

Dr Taslimarif Syed, CEO and Director, C- CAMP, moderated a panel discussion on 'Healthcare & Medical Electronics' with Dr Aditya Kulkarni,

WEITERE GESCHICHTEN VON Bio Spectrum

Bio Spectrum

Biotium's new cell barcoding kit streamlines flow cytometry with single-tube multiplexing

Biotium, a leading provider of fluorescent reagents and kits for life science research, has announced the release of the ViaPlex 2-Color Cell Barcoding Kit.

time to read

1 min

May 2026

Bio Spectrum

Bio Spectrum

NATHEALTH names Dr Sangita Reddy as new President

NATHEALTH, an apex body representing the Indian healthcare industry, has announced Dr Sangita Reddy, Joint Managing Director, Apollo Hospitals Group, as its new President for FY 2026-2027.

time to read

1 min

May 2026

Bio Spectrum

Rs 4.51 Lakh Crore Health Push: How State Budgets Are Powering India's Next Healthcare Leap

In recent years, state health budgets have transformed from simple financial documents into strategic instruments for improving healthcare outcomes.

time to read

7 mins

May 2026

Bio Spectrum

WHO lays focus on simulation exercises to strengthen health emergency readiness

To support countries to prepare more systematically against emergencies, WHO has recently released new global guidance which enables countries to move beyond oneoff emergency drills and establish National Health Simulation Exercise Programmes (NHSEP).

time to read

1 min

May 2026

Bio Spectrum

Bio Spectrum

Akrivia Biosciences decodes breast cancer genomic heterogeneity

Akrivia Biosciences, a cancer genomics startup based in London and Mumbai, has announced a foundational scientific breakthrough that uncovers hidden organisation of cancer genomes, successfully decoding breast cancer genomic heterogeneity, a major bottleneck that has historically hindered the comprehensive understanding of tumour biology in patients.

time to read

1 min

May 2026

Bio Spectrum

Bio Spectrum

Integrating AI for Tech-driven Ayurveda

A promising trend emerging in 2026 is the integration of artificial intelligence (AI) into ayurveda, to not only make ayurveda more accessible and scalable but to also create opportunities to back up ayurveda with science and technology.

time to read

2 mins

May 2026

Bio Spectrum

ASPIRE BIONEST signs MoU with Indian Immunologicals to advance One Health Innovation

ASPIRE BIONEST, a life sciences incubation centre at the University of Hyderabad, has signed a strategic Memorandum of Understanding (MoU) with Indian Immunologicals Ltd. (IIL), a leading vaccine-focused biotechnology company, to advance innovation under the One Health framework.

time to read

1 min

May 2026

Bio Spectrum

MSD India and Smile Foundation award 50 scholarships to aspiring pharmacy students

MSD (known as Merck & Co., Inc., Rahway, N.J., USA in the United States and Canada) in India has announced the awarding of scholarships to 50 students under its corporate social responsibility initiative 'Scholarship for Daughters' programme, a merit-based initiative aimed at supporting young women from underserved communities to pursue a Bachelor of Pharmacy degree at select accredited pharmacy colleges across India.

time to read

1 min

May 2026

Bio Spectrum

Bio Spectrum

Thermo Fisher launches integrated platform to accelerate biologics development

Thermo Fisher Scientific Inc. has announced a next-generation, integrated cell line development platform that enables biologics developers to accelerate time to clinic while maintaining regulatory confidence and commercial scalability.

time to read

1 min

May 2026

Bio Spectrum

Bio Spectrum

Eurofins Viracor unveils ExPECT anti-CD19 (obe-cel) CAR T-cell assay

Eurofins Viracor, a leader in advanced clinical diagnostics, has announced the launch of the ExPECT anti-CD19 (obe-cel) CAR T-cell assay, a cutting-edge solution designed to help clinicians monitor CAR T-cell therapy performance with validated precision and a quick turn-around-time for results.

time to read

1 min

May 2026

Listen

Translate

Share

-
+

Change font size